To further confirm the pro‐tumoral activity of HSD17B12, we conducted in vitro tumorigenic assays after applying RNA interference by siRNA transient transfection to diminish HSD17B12 expression in the SH‐SY5Y and NMB neuroblastoma cells (Figure4A,B). This evidence concerns the gene HSD17B12 and neuroblastoma.